Insiders Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Market Closed - Toronto S.E. Other stock markets 03:59:39 2024-05-17 pm EDT			5-day change	1st Jan Change
19.92 ^CAD	-4.05%		-5.59%	-12.13%

May. 06	Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	MT
May. 06	Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bausch + Lomb Corporation Announces Board Changes	Feb. 28	CI
RBC on Bausch Health CFO Transition Plan	23-09-19	MT
Bausch + Lomb Brief: Names Al Waterhouse, executive vice president and chief supply chain and operations officer	23-08-01	MT
Bausch + Lomb Brief: Names Asli Gevgilili, executive vice president and chief human resources officer	23-08-01	MT
Bausch + Lomb Brief: Announcing changes to its executive leadership team including the creation of two new roles	23-08-01	MT
Bausch + Lomb Corporation Announces Executive Changes	23-08-01	CI
Bausch + Lomb Details Leadership Changes	23-06-01	MT
Bausch + Lomb Corporation Announces Executive Changes	23-06-01	CI
Bausch + Lomb Brief: Announcing Key Leadership Changes	23-06-01	MT
Bausch + Lomb Corporation Announces Management Appointments, Effective April 24, 2023	23-04-12	CI
Bausch + Lomb Names Legal Chief, President of Ophthalmic Pharmaceuticals	23-04-12	MT
Bausch + Lomb Brief: Appointing Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals	23-04-12	MT
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer	23-02-15	MT
Bausch + Lomb Taps Brent Saunders as New Chief Executive Officer	23-02-15	MT
Bausch + Lomb Corporation Announces Board Appointments, Effective March 6, 2023	23-02-15	CI
Bausch + Lomb Corporation Appoints Brent Saunders as Chief Executive Officer, Effective March 6, 2023	23-02-15	CI
Bausch + Lomb and Its Outgoing Chief Executive Reach Amended Separation Agreement	22-12-22	MT
Bausch + Lomb Corporation Enters into CEO Separation Agreement with Joseph C. Papa	22-12-22	CI
Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments s.r.l. Intraocular Dyes	22-09-01	AQ
Bausch + Lomb Names Exclusive Global Distributor of Alfa Instruments S.R.L. Intraocular Dyes	22-09-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Insiders

Filters